Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.

As of ~~April 26,~~July 25, 2022, Addus HomeCare Corporation had ~~16,071,408~~ 16,080,337shares of Common Stock outstanding.


	March 31, 2022		December 31, 2021		June 30, 2022		December 31, 2021
Assets
Current assets
Cash	$	124,763	$	168,895	$	120,917	$	168,895
Accounts receivable, net of allowances		136,808		136,955
Accounts receivable, net of allowances for credit losses						124,554		136,955
Prepaid expenses and other current assets		14,658		18,491		10,901		18,491
Total current assets		276,229		324,341		256,372		324,341
Property and equipment, net of accumulated depreciation and amortization		19,073		18,483		17,733		18,483
Other assets
Goodwill		574,086		504,392		574,752		504,392
Intangibles, net of accumulated amortization		76,300		64,321		74,464		64,321
Operating lease assets, net		41,523		36,048		41,207		36,048
Total other assets		691,909		604,761		690,423		604,761
Total assets	$	987,211	$	947,585	$	964,528	$	947,585
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	21,004	$	19,358	$	21,346	$	19,358
Accrued payroll		27,720		44,083		39,432		44,083
Accrued expenses		38,820		37,077		38,054		37,077
Government stimulus advances		4,173		4,173		16,735		4,173
Accrued workers' compensation insurance		12,640		12,998		12,437		12,998
Total current liabilities		104,357		117,689		128,004		117,689
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs		256,127		220,912
Long-term debt, net of debt issuance costs						196,342		220,912
Long-term operating lease liabilities		39,049		32,859		38,343		32,859
Other long-term liabilities		1,900		1,781		2,062		1,781
Total long-term liabilities		297,076		255,552		236,747		255,552
Total liabilities	$	401,433	$	373,241	$	364,751	$	373,241
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 16,068 and 15,940 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	$	16	$	16
Common stock—$.001 par value; 40,000 authorized and 16,081 and 15,940 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively					$	16	$	16
Additional paid-in capital		383,001		380,037		385,750		380,037
Retained earnings		202,761		194,291		214,011		194,291
Total stockholders' equity		585,778		574,344		599,777		574,344
Total liabilities and stockholders' equity	$	987,211	$	947,585	$	964,528	$	947,585

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

	For the Three Months Ended March 31,						For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2022			2021			2022			2021			2022			2021
Net service revenues	$	226,634		$	205,302		$	236,940		$	217,893		$	463,574		$	423,195
Cost of service revenues		156,448			144,105			161,342			149,083			317,790			293,188
Gross profit		70,186			61,197			75,598			68,810			145,784			130,007
General and administrative expenses		53,152			45,426			55,095			48,175			108,247			93,601
Depreciation and amortization		3,521			3,601			3,609			3,587			7,130			7,188
Total operating expenses		56,673			49,027			58,704			51,762			115,377			100,789
Operating income		13,513			12,170			16,894			17,048			30,407			29,218
Interest income		(58	)		(22	)		(108	)		(31	)		(166	)		(53	)
Interest expense		1,820			1,216			1,986			1,262			3,806			2,478
Total interest expense, net		1,762			1,194			1,878			1,231			3,640			2,425
Income before income taxes		11,751			10,976			15,016			15,817			26,767			26,793
Income tax expense		3,281			2,082			3,766			4,220			7,047			6,302
Net income	$	8,470		$	8,894		$	11,250		$	11,597		$	19,720		$	20,491
Net income per common share
Basic income per share	$	0.54		$	0.57		$	0.71		$	0.74		$	1.25		$	1.30
Diluted income per share	$	0.53		$	0.55		$	0.70		$	0.72		$	1.22		$	1.28
Weighted average number of common shares and potential common shares outstanding:
Basic		15,811			15,694			15,854			15,738			15,833			15,716
Diluted		16,079			16,069			16,131			16,043			16,113			16,063

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

											For the Three Months Ended June 30, 2022
											Common Stock					Additional Paid-in Capital		Retained Earnings		Total Stockholders' Equity
											Shares			Amount
Balance at April 1, 2022												16,068		$	16	$	383,001	$	202,761	$	585,778
Issuance of shares of common stock under restricted stock award agreements												15			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements												(3	)		—		—		—		—
Stock-based compensation												—			—		2,680		—		2,680
Shares issued for exercise of stock options												1			—		69		—		69
Net income												—			—		—		11,250		11,250
Balance at June 30, 2022												16,081		$	16	$	385,750	$	214,011	$	599,777

	For the Three Months Ended March 31, 2022										For the Six Months Ended June 30, 2022
	Common Stock				Additional Paid-in		Retained		Total Stockholders'		Common Stock					Additional Paid-in Capital		Retained Earnings		Total Stockholders' Equity
	Shares		Amount		Capital		Earnings		Equity		Shares			Amount
Balance at January 1, 2022		15,940	$	16	$	380,037	$	194,291	$	574,344		15,940		$	16	$	380,037	$	194,291	$	574,344
Issuance of shares of common stock under restricted stock award agreements		115		—		—		—		—		130			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements												(3	)		—		—		—		—
Stock-based compensation		—		—		2,485		—		2,485		—			—		5,165		—		5,165
Shares issued for exercise of stock options		13		—		479		—		479		14			—		548		—		548
Net income		—		—		—		8,470		8,470		—			—		—		19,720		19,720
Balance at March 31, 2022		16,068	$	16	$	383,001	$	202,761	$	585,778
Balance at June 30, 2022												16,081		$	16	$	385,750	$	214,011	$	599,777

	For the Three Months Ended March 31, 2021
	Common Stock				Additional Paid-in		Retained		Total Stockholders'
	Shares		Amount		Capital		Earnings		Equity
Balance at January 1, 2021		15,826	$	16	$	369,495	$	149,165	$	518,676
Issuance of shares of common stock under restricted stock award agreements		75		—		—		—		—
Stock-based compensation		—		—		2,239		—		2,239
Shares issued for exercise of stock options		2		—		101		—		101
Net income		—		—		—		8,894		8,894
Balance at March 31, 2021		15,903	$	16	$	371,835	$	158,059	$	529,910

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

	For the Three Months Ended June 30, 2021
	Common Stock				Additional Paid-in Capital		Retained Earnings		Total Stockholders' Equity
	Shares		Amount
Balance at April 1, 2021		15,903	$	16	$	371,835	$	158,059	$	529,910
Issuance of shares of common stock under restricted stock award agreements		13		—		—		—		—
Stock-based compensation		—		—		2,525		—		2,525
Shares issued for exercise of stock options		1		—		23		—		23
Net income		—		—		—		11,597		11,597
Balance at June 30, 2021		15,917	$	16	$	374,383	$	169,656	$	544,055

	For the Six Months Ended June 30, 2021
	Common Stock				Additional Paid-in Capital		Retained Earnings		Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2021		15,826	$	16	$	369,495	$	149,165	$	518,676
Issuance of shares of common stock under restricted stock award agreements		88		—		—		—		—
Stock-based compensation		—		—		4,764		—		4,764
Shares issued for exercise of stock options		3		—		124		—		124
Net income		—		—		—		20,491		20,491
Balance at June 30, 2021		15,917	$	16	$	374,383	$	169,656	$	544,055

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

	For the Three Months						For the Six Months
	Ended March 31,						Ended June 30,
	2022			2021			2022			2021
Cash flows from operating activities:
Net income	$	8,470		$	8,894		$	19,720		$	20,491
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization		3,521			3,601			7,130			7,188
Deferred income taxes		126			165			291			396
Stock-based compensation		2,485			2,239			5,165			4,764
Amortization of debt issuance costs under the credit facility		215			184			430			368
Provision for doubtful accounts		158			252			318			529
Impairment of operating lease assets		1,174			—			1,174			—
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		7,121			(6,397	)		20,249			(6,232	)
Prepaid expenses and other current assets		4,161			(1,007	)		7,909			(3,004	)
Government stimulus advances		—			(11,719	)		12,562			(23,993	)
Accounts payable		1,386			(290	)		1,398			111
Accrued payroll		(17,443	)		(15,313	)		(5,756	)		(1,900	)
Accrued expenses and other long-term liabilities		(5,391	)		1,025			(8,088	)		(2,039	)
Net cash provided by (used in) operating activities		5,983			(18,366	)		62,502			(3,321	)
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		(84,490	)		—			(84,490	)		(81	)
Purchases of property and equipment		(1,104	)		(1,021	)		(1,538	)		(1,847	)
Net cash used in investing activities		(85,594	)		(1,021	)		(86,028	)		(1,928	)
Cash flows from financing activities:
Payments on revolver loan — credit facility								(60,000	)		—
Proceeds from borrowings on revolver — credit facility								35,000			—
Payments on term loan — credit facility		—			(245	)		—			(490	)
Borrowings on revolver — credit facility		35,000			—
Cash received from exercise of stock options		479			101			548			124
Net cash provided by (used in) financing activities		35,479			(144	)
Other								—			(63	)
Net cash used in financing activities								(24,452	)		(429	)
Net change in cash		(44,132	)		(19,531	)		(47,978	)		(5,678	)
Cash, at beginning of period		168,895			145,078			168,895			145,078
Cash, at end of period	$	124,763		$	125,547		$	120,917		$	139,400
Supplemental disclosures of cash flow information:
Cash paid for interest	$	1,619		$	1,174		$	3,403		$	2,136
Cash paid for income taxes								—			10,950
Acquisition consideration payable included in accrued expenses								1,605			—

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of 3 distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2021 has been derived from the Company’s audited financial statements for the year ended December 31, 2021 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2021 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles in business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

The following table sets forth the computation of basic and diluted common ~~shares for the three months ended March 31, 2022 and 2021:~~shares:

	For the Three Months Ended March 31,				For the Three Months Ended June 30,				For the Six Months Ended June 30,
	(Amounts in thousands)				(Amounts in thousands)				(Amounts in thousands)
	2022		2021		2022		2021		2022		2021
Weighted average number of shares outstanding for basic per share calculation		15,811		15,694		15,854		15,738		15,833		15,716
Effect of dilutive potential shares:
Stock options		235		311		241		285		237		298
Restricted stock awards		33		64		36		20		43		49
Adjusted weighted average shares for diluted per share calculation		16,079		16,069
Adjusted weighted average shares outstanding for diluted per share calculation						16,131		16,043		16,113		16,063
Anti-dilutive shares:
Stock options		92		—		111		73		111		73
Restricted stock awards		77		75		81		127		19		75

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. ASU 2021-10 requires entities to disclose certain information about the nature of certain governmental assistance received, including the nature of the transaction and the related accounting policy, the financial statement line items impacted by the assistance, as well as the significant terms and conditions of the transactions. The ASU was adopted as of January 1, 2022 and did not have an impact on the Company’s results of operations or liquidity.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. On July 30, 2021, the Company entered into the Second Amendment to the Credit Agreement as discussed further in Note 8. The Credit Agreement contains hardwired fallback language that contemplates a transition from LIBOR, specifically identifies the secured overnight financing rate (“SOFR”) as the replacement reference rate and details the mechanism for transition at LIBOR cessation, which is anticipated to occur on June 30, 2023. The transition to SOFR is not expected to have a material impact on the Company’s results of operations or liquidity.

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

	March 31, 2022		December 31, 2021		June 30, 2022		December 31, 2021
	(Amounts in Thousands)				(Amounts in Thousands)
Operating lease assets, net	$	41,523	$	36,048	$	41,207	$	36,048

Short-term operating lease liabilities (in accrued expenses)		10,766		9,774		10,702		9,774
Long-term operating lease liabilities		39,049		32,859		38,343		32,859
Total operating lease liabilities	$	49,815	$	42,633	$	49,045	$	42,633

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended March 31, (Amounts in Thousands)						For the Three Months Ended June 30, (Amounts in Thousands)						For the Six Months Ended June 30, (Amounts in Thousands)
	2022			2021			2022			2021			2022			2021
Operating lease costs	$	2,801		$	2,777		$	3,103		$	2,775		$	5,904		$	5,552
Short-term lease costs		751			181			911			194			1,662			375
Total lease costs		3,552			2,958			4,014			2,969			7,566			5,927
Less: sublease income		(177	)		(151	)		(176	)		(152	)		(353	)		(303	)
Total lease costs, net	$	3,375		$	2,807		$	3,838		$	2,817		$	7,213		$	5,624

~~Weighte~~dWeighted average remaining lease terms and discount rates were as follows:

	March 31, 2022			December 31, 2021			June 30, 2022			December 31, 2021
Operating leases:
Weighted average remaining lease term		6.27			6.39
Weighted average remaining lease term (years)								6.16			6.39
Weighted average discount rate		3.80	%		3.91	%		3.86	%		3.91	%

Remaining operating lease payments as of ~~March 31,~~June 30, 2022 were as follows:

	Operating Leases			Operating Leases
	(Amounts in Thousands)			(Amounts in Thousands)
Due in the 12-month period ended March 31,
Due in the 12-month period ended June 30,
2023	$	12,329		$	12,213
2024		10,706			10,592
2025		8,476			8,177
2026		5,493			5,730
2027		4,574			4,611
Thereafter		14,748			14,069
Total future minimum rental commitments		56,326			55,392
Less: Imputed interest		(6,511	)		(6,347	)
Total lease liabilities	$	49,815		$	49,045

	For the Three Months Ended March 31,				For the Six Months Ended June 30,
	(Amounts in Thousands)				(Amounts in Thousands)
	2022		2021		2022		2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3,194	$	2,517	$	6,476	$	5,313

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	9,199	$	2,675	$	11,319	$	3,919

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

On February 1, 2022, wethe Company completed the acquisition of the hospice and palliative operations of JourneyCare Inc. (“JourneyCare”). The purchase price was approximately ~~$85.0~~$86.6 million, including the amount of acquired excess cash held by JourneyCare at the closing of the acquisition (approximately ~~$0.5~~$0.5 million). plus the finalization of net working capital payable to seller of $1.6 million. The JourneyCare acquisition was funded with a combination of a ~~$35.0~~$35.0 million draw on the Company’s revolving credit facility and available cash. With the JourneyCare acquisition, the Company expanded its hospice services in the state of Illinois. The related acquisition costs were $0.2 million and $0.5 million for the three and six months ended June 30, 2022, respectively, and integration costs were ~~$0.3~~$1.3 million and ~~$1.8~~$3.1 million ~~respectively,~~ for the three and six months ended ~~March 31, 2022.~~June 30, 2022, respectively. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities acquired are as follows:

	Total (Amounts in Thousands)			Total (Amounts in Thousands)
Goodwill	$	70,153		$	70,775
Identifiable intangible assets		13,792			13,792
Cash		500			500
Accounts receivable		7,080			8,120
Property and equipment					1,194
Operating lease assets, net		3,728			3,728
Other assets		280			333
Property and equipment		1,194
Accrued expenses		(6,714	)		(6,799	)
Accrued payroll		(1,486	)		(1,511	)
Long-term operating lease liabilities		(3,537	)		(3,537	)
Total purchase price	$	84,990		$	86,595

Identifiable intangible assets acquired included $9.0 million in a trade name and $4.8 million of indefinite lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The JourneyCare acquisition accounted for ~~$9.5~~$13.6 million and $23.1 million of net service revenues and ~~$2.0~~$2.6 million and $4.6 million of operating income for the three and six months ended ~~March 31, 2022.~~June 30, 2022, respectively.

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the three and six months ended ~~March 31,~~June 30, 2022 as if the JourneyCare acquisition closed on January 1, 2021.

	For the Three Months Ended March 31, (Amounts in Thousands)				For the Three Months Ended June 30, (Amounts in Thousands)				For the Six Months Ended June 30, (Amounts in Thousands)
	2022		2021		2022		2021		2022		2021
Net service revenues	$	231,847	$	219,920	$	236,940	$	232,469	$	468,787	$	452,389
Operating income		12,240		10,936		16,921		16,340		29,161		27,276
Net income		7,629		7,894		11,315		11,078		18,921		19,005
Net income per common share
Basic income per share	$	0.48	$	0.50	$	0.71	$	0.70	$	1.20	$	1.21
Diluted income per share	$	0.47	$	0.49	$	0.70	$	0.69	$	1.17	$	1.18

The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions as if the operations of JourneyCare had been acquired effective January 1, 2021. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.

	Hospice			Personal Care		Home Health			Total			Hospice			Personal Care		Home Health			Total
	(Amounts in Thousands)											(Amounts in Thousands)
Goodwill as of December 31, 2021	$	328,334		$	152,688	$	23,370		$	504,392		$	328,334		$	152,688	$	23,370		$	504,392
Additions for acquisitions		70,153			—		—			70,153			70,775			—		—			70,775
Adjustments to previously recorded goodwill		(113	)		—		(346	)		(459	)		(91	)		—		(324	)		(415	)
Goodwill as of March 31, 2022	$	398,374		$	152,688	$	23,024		$	574,086
Goodwill as of June 30, 2022												$	399,018		$	152,688	$	23,046		$	574,752

In connection with the JourneyCare acquisition, the Company recognized goodwill in its hospice segment of ~~$70.2~~$70.8 million, during the ~~three~~six months ended ~~March 31,~~June 30, 2022. See Note 4 for additional information regarding the acquisition.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from five to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of ~~March 31,~~June 30, 2022:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total			Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)															(Amounts in Thousands)
Intangible assets with indefinite lives	$	—		$	—		$	—		$	25,901		$	25,901		$	—		$	—		$	—		$	25,891		$	25,891
Intangible assets subject to amortization:
Gross carrying amount		44,672			51,941			6,785			12,508			115,906			44,672			51,941			6,785			12,517			115,915
Accumulated amortization		(36,779	)		(19,126	)		(4,081	)		(5,521	)		(65,507	)		(37,215	)		(19,773	)		(4,331	)		(6,023	)		(67,342	)
Intangible assets subject to amortization, net		7,893			32,815			2,704			6,987			50,399			7,457			32,168			2,454			6,494			48,573
Total intangible assets at March 31, 2022	$	7,893		$	32,815		$	2,704		$	32,888		$	76,300
Total intangible assets at June 30, 2022																$	7,457		$	32,168		$	2,454		$	32,385		$	74,464

In connection with the JourneyCare acquisition, the Company recognized a trade name of $9.0 million and indefinite lived state licenses of $4.8 million in its hospice segment during the three months ended March 31, 2022. See Note 4 for additional information regarding the acquisition.

Amortization expense related to the intangible assets was $1.8 million and ~~$2.2~~$3.6 million for the three and six months ended ~~March 31,~~June 30, 2022, respectively, and $2.1 million and $4.3 million for the three and six months ended June 30, 2021, respectively. The weighted average remaining useful lives of identifiable intangible assets as of ~~March 31,~~June 30, 2022 was ~~10.2~~10.0 years.

	March 31, 2022		December 31, 2021		June 30, 2022		December 31, 2021
	(Amounts in Thousands)				(Amounts in Thousands)
Income tax receivable	$	4,333	$	7,556
Prepaid workers' compensation and liability insurance		2,070		3,206	$	3,520	$	3,206
Workers' compensation insurance receivable		1,073		1,559		783		1,559
Income tax receivable						737		7,556
Other		7,182		6,170		5,861		6,170
Total prepaid expenses and other current assets	$	14,658	$	18,491	$	10,901	$	18,491

	March 31, 2022		December 31, 2021		June 30, 2022		December 31, 2021
	(Amounts in Thousands)				(Amounts in Thousands)
Current portion of operating lease liabilities	$	10,766	$	9,774	$	10,702	$	9,774
Payor advances (1)						5,404		6,485
Accrued health insurance		6,637		5,200		5,381		5,200
Payor advances⁽¹⁾		5,866		6,485
Accrued professional fees		3,357		2,978		3,435		2,978
Other		12,194		12,640		13,132		12,640
Total accrued expenses	$	38,820	$	37,077	$	38,054	$	37,077

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress took dramatic actions to provide liquidity to businesses and the banking system in the United States, as described below.

One of the primary sources of relief for healthcare providers is the Provider Relief Fund, which has been funded through the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) and related legislation. Provider Relief Fund payments are intended to compensate healthcare providers for lost revenues and health care related expenses incurred in response to the COVID-19 pandemic and are not required to be repaid, provided that recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using funds received from the Provider Relief Fund to reimburse expenses or losses that other sources are obligated to reimburse. Commercial organizations that receive and expend annual total awards of $750,000 or more in federal funding, including payments received through the Provider Relief Fund, are subject to federal audit requirements.

In November 2020, the Company received grants in an aggregate principal amount of $13.7 million from the Provider Relief Fund, and fully utilized these funds as of December 31, 2021, including ~~$0.9~~$10.4 million and $11.3 million during the three and six months ended ~~March 31,~~June 30, 2021, respectively, for healthcare related expenses, including retention payments, attributable to COVID-19 that were unreimbursed by other sources. We were required to properly and fully document the use of such funds in reports to the U.S. Department of Health & Human Services (“HHS”), which we were required to submit no later than March 31, 2022. We have submitted the required reports.

The CARES Act also provided for certain federal income and other tax changes, including allowing for the deferral of the employer portion of Social Security payroll taxes through December 31, 2020. The Company received a cash benefit of approximately $7.1 million related to the deferral of employer payroll taxes for 2020 under the CARES Act, for the period April 2, 2020 through June 30, 2020. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the deferred portion of employer Social Security payroll taxes was $4.1 million, which is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets. The payroll tax deferral requires that the remaining deferred payroll taxes be paid by December 31, 2022.

The American Rescue Plan Act of 2021 (“ARPA”), which became law on March 11, 2021, provides for $350 billion in relief funding for eligible state, local, territorial, and Tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provides for a 10-percentage point increase in federal matching funds for Medicaid home and community based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, ~~2024.~~2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

the six months ended June 30, 2022, the Company received state funding provided by the ARPA in an aggregate amount of $14.6 million. The Company recorded revenue of $1.6 million and related cost of service revenues of $1.2 million for certain states that met the revenue recognition criteria.The Company deferred the remaining $13.0 million, which was received from states with specific spending plans and reporting requirements. The Company utilized $0.4 million of these funds during the three and six months ended June 30, 2022, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2022, the deferred portion of ARPA funding was $12.6 million, which is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

The CARES Act and related laws temporarily lifted the Medicare sequester which would have otherwise reduced payments to Medicare providers by 2%, as required by the Budget Control Act of 2011, from May 1, 2020, through December 31, 2021 (but also extended sequestration through 2030). Congress further delayed these sequestration cuts through March 31, 2022, and reduced the sequestration adjustment to 1% from April 1 through June 30, 2022. The full 2% reduction ~~is currently scheduled to resume~~resumed July 1, 2022. These sequestration cuts have been extended through 2030, with the reductions for 2030 set to increase to 2.25% for the first six months and to 3% for the second six months.

In the hospice segment, Medicare sequester relief resulted in an increase in net service revenues of ~~$0.9~~$0.5 million and $0.7 million for the three months ended ~~March 31,~~June 30, 2022 and 2021, ~~respectively.~~ respectively, and $1.4 million for each of the six months ended June 30, 2022 and 2021. In the home health segment, Medicare sequester relief resulted in an increase in net service revenues of ~~$0.2 million and~~ $0.1 million for each of the three months ended ~~March 31,~~June 30, 2022 and 2021, and $0.3 million and $0.2 million for the six months ended June 30, 2022 and 2021, respectively.

The ARPA increases the federal budget deficit in a manner that triggers an additional statutorily mandated sequestration under the Pay-As-You-Go Act of 2010 (“PAYGO Act”). As a result, an additional Medicare payment reduction of up to 4% was required to take effect in January 2022. However, Congress delayed implementation of this payment reduction until 2023. We cannot currently determine if, or to what extent, our business, results of operations, financial condition or liquidity will ultimately be impacted by mandated sequestration triggers under the PAYGO Act, or if or when the mandated sequestration will ~~occur~~.occur.

For the three and six months ended ~~March 31,~~June 30, 2022, ~~and 2021,~~ COVID-19-related expenses in our personal care segment were approximately ~~$1.7~~$1.1 million and ~~$0.9~~$2.8 million, respectively, and are included in cost of service revenues on the Consolidated Statements of Income. For the three and six months ended June 30, 2021, COVID-19-related expenses in our personal care segment were approximately $11.4 million and $13.3 million, respectively, which were offset by $10.4 million and $11.3 million, respectively, related to the utilization of a portion of the funds received from the Provider Relief Fund in November 2020 and included in cost of service revenues on the Condensed Consolidated Statements of Income. Additionally, the Company recognized revenue of ~~$1.4~~$1.6 million and ~~$1.8~~$3.0 million attributable to temporary rate increases from certain payors in our personal care segment for the three and six months ended ~~March 31,~~June 30, 2022, respectively, and $3.1 million and $4.8 million for the three and six months ended June 30, 2021, respectively.

For the three and six months ended June 30, 2021, COVID-19-related expenses in our hospice segment were approximately $1.9 million, which were offset by $1.9 million, related to the utilization of a portion of the funds received from the Queen City Hospice Provider Relief Fund and included in cost of service revenues on the Condensed Consolidated Statements of Income.

Although the United States has ~~recently~~ experienced a moderation of infection and related hospitalization rates, there continues to be a significant number of COVID-19 cases and deaths in the United States and throughout the world. Given the longer-term uncertainties associated with the COVID-19 pandemic, it is impossible to predict the effect and ultimate impact of the COVID-19 pandemic on the Company as conditions related to the COVID-19 pandemic continue to evolve.

	March 31, 2022			December 31, 2021			June 30, 2022			December 31, 2021
	(Amounts in Thousands)						(Amounts in Thousands)
Revolving loan under the credit facility	$	259,853		$	224,853		$	199,853		$	224,853
Less unamortized issuance costs		(3,726	)		(3,941	)		(3,511	)		(3,941	)
Long-term debt	$	256,127		$	220,912		$	196,342		$	220,912

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, dated as of October 31, 2018, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, and as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021 (as amended, the “Credit Agreement”; as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $600.0 million revolving credit facility and a $125.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2026. Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement

contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures. The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed ~~$7.5~~$7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement thresholds), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

TheThe Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility. The credit facility contains hardwired fallback language that contemplates a transition from LIBOR, and specifically identifies SOFR as the replacement reference rate and details the mechanism for transition at LIBOR cessation, which is anticipated to occur on June 30, 2023. The transition to SOFR is not expected to have a material impact on the Company’s results of operations or liquidity.

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, the Company (i) drew $35.0 million under its credit facility to fund, in part, the JourneyCare ~~acquisition.~~acquisition and (ii) repaid $60.0 million under the revolving credit facility. During the ~~three~~six months ended ~~March 31,~~June 30, 2021, the Company had 0 draws under its credit facility.

At ~~March 31,~~June 30, 2022, the Company had a total of ~~$259.9~~$199.9 million of revolving loans, with an interest rate of ~~2.46%~~3.67%,, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $8.1 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had ~~$377.6~~$376.4 million of capacity and ~~$109.6~~$168.4 million available for borrowing under its credit facility.As of December 31, 2021, the Company had a total of $224.9 million of revolving loans, with an interest rate of 2.10%,outstanding on its credit ~~facility.~~facility.

As of ~~March 31,~~June 30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.

The effective income tax rates were ~~27.9%~~25.1% and ~~19.0%~~26.7% for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively.

The difference between our federal statutory and effective income tax rates is principally due to the inclusion of state taxes, non-deductible compensation and an excess tax expense, partially offset by the use of federal employment tax credits.

The effective income tax rates were 26.3% and 23.5% for the six months ended June 30, 2022 and 2021, respectively. For the ~~three~~six months ended ~~March 31,~~June 30, 2022, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, and excess tax expense, partially offset by the use of federal employment tax credits. For the six months ended June 30, 2022 and 2021, the effective tax rates were inclusive of an excess tax expense of ~~2.7%~~1.2% and an excess tax benefit of ~~7.4%~~3.0%, respectively. The excess tax expense or benefit is a discrete item, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense ~~or benefit~~ results if the Company’s cumulative costs of the award recognized exceed the income tax deduction on the Unaudited Condensed Consolidated Statements of Income, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction on the Unaudited Condensed Consolidated Statements of Income.

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

On June 2, 2021, the Company received a $6.5 million Request for Repayment from Palmetto, GBA, LLC (“Palmetto”), a Medicare administrative contractor, regarding Ambercare Hospice Inc. (“Ambercare”), our subsidiary that provides hospice services in New Mexico. In 2018, the Office of Audit Services (“OAS”), under the HHS Office of Inspector General, initiated a clinical review of certain hospice claims billed during a timeframe from January 1, 2016 to December 31, 2017. The OAS review concluded that certain payments to Ambercare for

hospice services during the review period were made in error. The Company acquired Ambercare in May 2018 and has a contractual right to full indemnification from any potential losses from the OAS review through the terms of the Ambercare purchase agreement. The Company disputes the results of the OAS review and related asserted billing errors and is in the process of filing administrative appeals. At this stage, the Company cannot predict the ultimate outcome of the appeal process.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of 3 distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments, ~~for the three months ended March 31, 2022 and 2021~~ along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

	For the Three Months Ended March 31, 2022								For the Three Months Ended June 30, 2022
	(Amounts in Thousands)								(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total		Personal Care		Hospice		Home Health		Total
Net service revenues	$	169,632	$	47,727	$	9,275	$	226,634	$	174,330	$	52,074	$	10,536	$	236,940
Cost of services revenues		126,291		23,441		6,716		156,448		128,682		25,522		7,138		161,342
Gross profit		43,341		24,286		2,559		70,186		45,648		26,552		3,398		75,598
General and administrative expenses		15,004		11,712		2,359		29,075		15,447		13,036		2,501		30,984
Segment operating income	$	28,337	$	12,574	$	200	$	41,111	$	30,201	$	13,516	$	897	$	44,614

~~For the three months ended March 31, 2022 and 2021, the~~The Company’s revenue by payor type was as follows:


Personal Care Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	83,908		49.5	%	$	80,849		49.0	%	$	85,462		49.0	%	$	88,382		50.2	%	$	169,370		49.2	%	$	169,231		49.6	%
Managed care organizations		77,390		45.6			75,456		45.8			80,577		46.2			78,865		44.7			157,967		45.9			154,321		45.2
Private pay		4,626		2.7			4,903		3.0			4,610		2.7			5,046		2.9			9,236		2.7			9,949		2.9
Commercial insurance		2,024		1.2			2,346		1.4			2,093		1.2			2,676		1.5			4,117		1.2			5,022		1.5
Other		1,684		1.0			1,314		0.8			1,588		0.9			1,298		0.7			3,272		1.0			2,612		0.8
Total personal care segment net service revenues	$	169,632		100.0	%	$	164,868		100.0	%	$	174,330		100.0	%	$	176,267		100.0	%	$	343,962		100.0	%	$	341,135		100.0	%

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	47,152		90.5	%	$	34,452		93.3	%	$	90,637		90.8	%	$	68,437		93.8	%
Commercial insurance		2,726		5.2			959		2.6			4,970		5.0			1,492		2.0
Managed care organizations		1,968		3.8			1,395		3.8			3,683		3.7			2,882		3.9
Other		228		0.5			103		0.3			511		0.5			192		0.3
Total hospice segment net service revenues	$	52,074		100.0	%	$	36,909		100.0	%	$	99,801		100.0	%	$	73,003		100.0	%


Home Health Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	6,812		73.4	%	$	3,502		80.7	%	$	7,592		72.1	%	$	3,825		81.1	%	$	14,404		72.7	%	$	7,327		80.9	%
Managed care organizations		1,904		20.5			798		18.4			2,262		21.5			822		17.4			4,166		21.0			1,620		17.9
Other		559		6.1			40		0.9			682		6.4			70		1.5			1,241		6.3			110		1.2
Total home health segment net service revenues	$	9,275		100.0	%	$	4,340		100.0	%	$	10,536		100.0	%	$	4,717		100.0	%	$	19,811		100.0	%	$	9,057		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico and New York. The percentages of segment revenue for each of these significant states for the three and six months ended ~~March 31,~~June 30, 2022 and 2021 were as follows:


Personal Care Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	84,693		49.9	%	$	73,385		44.5	%	$	88,797		50.9	%	$	84,788		48.0	%	$	173,480		50.4	%	$	158,172		46.3	%
New Mexico		25,440		15.0			23,593		14.3			26,473		15.2			25,484		14.5			51,912		15.1			49,077		14.4
New York ⁽¹⁾		21,385		12.6			27,575		16.7			21,127		12.1			25,535		14.5			42,513		12.4			53,110		15.6
All other states		38,114		22.5			40,315		24.5			37,933		21.8			40,460		23.0			76,057		22.1			80,776		23.7
Total personal care segment net service revenues	$	169,632		100.0	%	$	164,868		100.0	%	$	174,330		100.0	%	$	176,267		100.0	%	$	343,962		100.0	%	$	341,135		100.0	%


Hospice Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Ohio	$	16,328		34.2	%	$	14,114		39.1	%	$	17,245		33.1	%	$	14,694		39.8	%	$	33,574		33.7	%	$	28,808		39.4	%
Illinois ⁽²⁾		9,541		20.0			—		—			13,561		26.0			—		—			16,078		16.1			—		—
New Mexico		8,233		17.3			9,230		25.6			7,846		15.1			8,717		23.6			23,102		23.1			17,948		24.6
All other states		13,625		28.5			12,750		35.3			13,422		25.8			13,498		36.6			27,047		27.1			26,247		36.0
Total hospice segment net service revenues	$	47,727		100.0	%	$	36,094		100.0	%	$	52,074		100.0	%	$	36,909		100.0	%	$	99,801		100.0	%	$	73,003		100.0	%


Home Health Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	7,509		81.0	%	$	4,340		100.0	%	$	9,070		86.1	%	$	4,717		100.0	%	$	16,579		83.7	%	$	9,057		100.0	%
Illinois ⁽³⁾		1,766		19.0			—		—			1,466		13.9			—		—			3,232		16.3			—		—
Total home health segment net service revenues	$	9,275		100.0	%	$	4,340		100.0	%	$	10,536		100.0	%	$	4,717		100.0	%	$	19,811		100.0	%	$	9,057		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented ~~42.4%~~43.8%, and ~~35.8%~~38.9% of our net service revenues for the three months ended ~~March 31,~~June 30, 2022, and 2021, respectively, and accounted for 41.6% and 37.4% of our net service revenues for the six months ended June 30, 2022 and 2021, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 20.7% and ~~20.4%~~22.6% of the Company’s net service revenues for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively, and accounted for 20.7% and 21.5% of the Company’s net service revenues for the six months ended June 30, 2022 and 2021, respectively.

The related receivables due from the Illinois Department on Aging represented 18.3% and 16.1% of the Company’s net accounts receivable at ~~both March 31,~~June 30, 2022 and December 31, ~~2021.~~2021, respectively.

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the anticipated impact to our business with respect to developments related to the COVID-19 pandemic, including, without limitation, those related to the length and severity of the pandemic, as well as the timing, availability and acceptance of effective medical treatments, vaccines and booster shots; the spread of potentially more contagious and/or virulent forms of the virus; the pandemic’s impact on our operations, reimbursement and our consumer population; measures we are taking to respond to the pandemic; the impact of government regulation, stimulus and relief measures, including the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”), the Consolidated Appropriations Act, 2021 (“CAA”), the COVID-Related Tax Relief Act of 2020, the American Rescue Plan of 2021 (“ARPA”) and any other stimulus or relief legislation, along with the related uncertainties regarding such measures and any future measures related to COVID-19; negative economic conditions in the United States, including inflationary conditions; increased expenses related to personal protective equipment (“PPE”), labor, supply chain, or other ~~expenditures;~~expenditures, including as a result of inflationary conditions; workforce disruptions, including shortages and increased labor expenses, associated with competitive labor market ~~conditions and the impact of quarantines;~~conditions; the impact of vaccine mandates on the workforce; and supply shortages and disruptions; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates; changes in, or our failure to comply with, existing, federal and state laws or regulations, or our failure to comply with new government laws or regulations on a timely basis; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to the overall economic conditions, ~~including economic and business conditions resulting from the COVID-19 pandemic,~~ and deficit spending by federal and state governments; cost containment initiatives undertaken by federal, state and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; business disruptions due to natural disasters, acts of terrorism, pandemics, riots, civil insurrection or social unrest, looting, protests, strikes or street demonstrations; our ability to integrate and manage our information systems; our ability to prevent cyber-attacks or security breaches to protect our information technology systems and confidential consumer data; our expectations regarding the size and growth of the market for our services; the acceptance of privatized social services; our expectations regarding changes in reimbursement rates; eligibility standards and limits on services imposed by state governmental agencies; the potential for litigation; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating and integrating acquisition opportunities and expand into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates; the impact of public health emergencies, including the COVID-19 pandemic; the impact of inclement weather or natural disasters; and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2021, filed with the SEC on February 25, 2022. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

We are a home care services provider operating three segments: personal care, hospice and home health. Our services are principally provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care revenues accounted for ~~35.7%~~35.8% and ~~37.9%~~37.2% of our net service revenues during the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively, and 35.8% and 37.5% of our net service revenues during the six months ended June 30, 2022 and 2021, respectively.

A summary of certain consolidated financial results ~~for~~ ~~the three months ended March 31, 2022 and 2021~~ is provided in the table below.

	For the Three Months Ended March 31,				For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2022		2021		2022		2021		2022		2021
Net service revenues by segment:	(Amounts in Thousands)				(Amounts in Thousands)				(Amounts in Thousands)
Personal care	$	169,632	$	164,868	$	174,330	$	176,267	$	343,962	$	341,135
Hospice		47,727		36,094		52,074		36,909		99,801		73,003
Home health		9,275		4,340		10,536		4,717		19,811		9,057
Total net service revenue	$	226,634	$	205,302
Total net service revenues					$	236,940	$	217,893	$	463,574	$	423,195

Net income	$	8,470	$	8,894	$	11,250	$	11,597	$	19,720	$	20,491

As of ~~March 31,~~June 30, 2022, we provided our services in 22 states through ~~207~~206 offices. We served approximately ~~53,000~~58,000 and ~~50,000~~56,000 discrete individuals, respectively, during the ~~three~~six months ended ~~March 31,~~June 30, 2022 and ~~2021, respectively.~~2021. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes and hospice facilities.

Although the United States has ~~recently~~ experienced a moderation of infection and related hospitalization rates, there continues to be a significant number of COVID-19 cases and deaths in the United States and throughout the world. ~~Moreover, while~~ economic conditions in the United States have continued to improve in the first quarter of 2022 compared to earlier pandemic levels, inflationary pressures, competitive labor market conditions and supply chain disruptions continue to impact the U.S. economy. The long-term trends of new cases and deaths in the United States and the future impact of the pandemic ~~continues~~continue to be unknown.

CMS issued an interim rule in November 2021 requiring COVID-19 vaccinations for Medicare- and Medicaid-certified providers and suppliers, including hospices and home health agencies, which covers clinical staff, individuals providing services under arrangements, volunteers and staff who are not involved in direct patient care. Additionally, some states have implemented, or may implement in the future, vaccine mandates with respect to healthcare personnel. It is currently difficult to predict the impact that any of these vaccine mandates may have on us or the extent to which these vaccine mandates will ultimately become effective. However, we expect that these rules, to the extent that they become effective, will impact our home health and hospice segments.

We are monitoring developments as information becomes available, including with respect to national, state and local vaccine mandates, to access the possible impact on our workforce in personal care, home health, hospice and our corporate support centers. We have developed a multistep program in order to strongly encourage our employees to get the COVID-19 vaccine, which included offering a vaccine stipend and incentives as well as creating educational and motivational leadership communication. These educational and motivational leadership communications are ongoing. We are actively engaged in an effort to track primary vaccination rates, which include the first and second doses, among caregivers and to continue to improve those rates. However, it is difficult to predict the future impact of the pandemic, including the impact of the President’s National COVID-19 Preparedness Plan and the implementation of existing and potential additional federal, state and local vaccine mandates on economic conditions in the United States and our business at this time.

For the three and six months ended ~~March 31,~~June 30, 2022, ~~and 2021,~~ COVID-19-related expenses in our personal care segment were approximately ~~$1.7~~$1.1 million and ~~$0.9~~$2.8 million, respectively, and are included in cost of service revenues on the Consolidated Statements of Income. For the three and six months ended June 30, 2021, COVID-19-related expenses in our personal care segment were approximately $11.4 million and $13.3 million, respectively, which were offset by $10.4 million and $11.3 million, respectively, related to the utilization of a portion of the funds received from the Provider Relief Fund in November 2020 and included in cost of service revenues on the Condensed Consolidated Statements of Income. Additionally, we recognized revenue of ~~$1.4~~$1.6 million and ~~$1.8~~$3.0 million attributable to temporary rate increases from certain payors in our personal care segment for the three and six months ended ~~March 31,~~June 30, 2022, respectively, and $3.1 million and $4.8 million for the three and six months ended June 30, 2021, respectively.

As of ~~March 31,~~June 30, 2022, the Company deferred the recognition of ~~$5.9~~$5.4 million of payments received from payors for COVID-19 reimbursement, included within accrued expenses, which will be recognized as we incur specific expenses related to the pandemic, such as expenses related to acquiring additional PPE and COVID-19 related paid time off, or will be returned to the extent COVID-19-related expenses are not incurred. We are not able to reasonably predict the total costs we will incur related to the COVID-19 pandemic, and such costs could be substantial.

Federal and state agencies continue to issue regulations and guidance related to the COVID-19 pandemic, and the public health situation continues to evolve, and, therefore, we cannot currently predict with certainty the extent to which our business, results of operations, financial condition or liquidity will ultimately be impacted by the pandemic. We will continue to assess the impact and consequences of the COVID-19 pandemic and government responses to the pandemic, including the implementation of the CARES Act, the PPPHCE Act, the CAA, the ARPA, other stimulus and relief legislation, the President’s National COVID-19 Preparedness Plan, and existing and potential additional federal, state and local vaccine mandates, on our business, results of operations, financial condition and cash flows. Given the dynamic nature of these circumstances, the related financial effect cannot be reasonably estimated at this time but is not expected to materially adversely impact our business. See Part I, Item 1A—Risk Factors — “The COVID-19 pandemic could negatively affect our operations, business and financial condition, and our liquidity could also be negatively impacted, particularly if the U.S. economic and/or public health conditions deteriorate in connection with the pandemic” of our Annual Report on Form 10-Kfor the year ended December 31, 2021, filed with the SEC on February 25, ~~2022.~~2022.

See “Liquidity and Capital Resources” below for additional information regarding funds received related to COVID-19 pandemic relief.

As the labor market has tightened and unemployment has declined in comparison to earlier levels, the competition for new caregivers, including skilled healthcare staff, and support staff has ~~increased significantly.~~ increased. In addition, the United States economy continues to experience significant inflationary pressures and a competitive labor market. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services. The increased staffing challenges, including COVID-19 related quarantine requirements ~~related to the Omicron surge, have~~and inflationary pressures, resulted in increased labor ~~cost~~costs to satisfy our staffing requirements during the three and six months ended ~~March 31,~~June 30, 2022 compared to 2021 in our non-clinical and clinical operations.

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations.

On August 1, 2021, we completed the acquisition of Armada Skilled Homecare of New Mexico LLC, Armada Hospice of New Mexico LLC and Armada Hospice of Santa Fe LLC (collectively, “Armada”) for approximately $29.8 million, including the amount of acquired excess cash held by Armada at the closing of the acquisition (approximately $0.7 million), with funding provided by our revolving credit facility. With the purchase of Armada, we expanded our home health and hospice services in the state of New Mexico.

On October 1, 2021, we completed the acquisition of Summit Home Health, LLC (“Summit”) for approximately $8.1 million, with funding provided by available cash. With the purchase of Summit, we added clinical services in Illinois to our home health segment.

On February 1, 2022, we completed the acquisition of the hospice and palliative operations of JourneyCare, Inc. (“JourneyCare”) for approximately ~~$85.0~~$86.6 million,including the amount of acquired excess cash held by JourneyCare at the closing of the acquisition (approximately ~~$0.5~~$0.5 million), plus the finalization of net working capital payable to seller of $1.6 million, with funding provided through a combination of a $35.0 million draw under the revolving credit facility and available cash on hand. With the JourneyCare acquisition, ~~the Company adds~~we added hospice services in Illinois.

Our payors are principally federal, state and local governmental agencies and managed care organizations. The federal, state and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

~~For the three months ended March 31, 2022 and 2021, our~~Our revenue by payor and significant states by segment were as follows:

Personal Care Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	83,908		49.5	%	$	80,849		49.0	%	$	85,462		49.0	%	$	88,382		50.2	%	$	169,370		49.2	%	$	169,231		49.6	%
Managed care organizations		77,390		45.6			75,456		45.8			80,577		46.2			78,865		44.7			157,967		45.9			154,321		45.2
Private pay		4,626		2.7			4,903		3.0			4,610		2.7			5,046		2.9			9,236		2.7			9,949		2.9
Commercial insurance		2,024		1.2			2,346		1.4			2,093		1.2			2,676		1.5			4,117		1.2			5,022		1.5
Other		1,684		1.0			1,314		0.8			1,588		0.9			1,298		0.7			3,272		1.0			2,612		0.8
Total personal care segment net service revenues	$	169,632		100.0	%	$	164,868		100.0	%	$	174,330		100.0	%	$	176,267		100.0	%	$	343,962		100.0	%	$	341,135		100.0	%
Illinois	$	84,693		49.9	%	$	73,385		44.5	%	$	88,797		50.9	%	$	84,788		48.0	%	$	173,480		50.4	%	$	158,172		46.3	%
New Mexico		25,440		15.0			23,593		14.3			26,473		15.2			25,484		14.5			51,912		15.1			49,077		14.4
New York ⁽¹⁾		21,385		12.6			27,575		16.7			21,127		12.1			25,535		14.5			42,513		12.4			53,110		15.6
All other states		38,114		22.5			40,315		24.5			37,933		21.8			40,460		23.0			76,057		22.1			80,776		23.7
Total personal care segment net service revenues	$	169,632		100.0	%	$	164,868		100.0	%	$	174,330		100.0	%	$	176,267		100.0	%	$	343,962		100.0	%	$	341,135		100.0	%

Hospice Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	43,485		91.1	%	$	33,985		94.2	%	$	47,152		90.5	%	$	34,452		93.3	%	$	90,637		90.8	%	$	68,437		93.8	%
Commercial insurance		2,244		4.7			533		1.5			2,726		5.2			959		2.6			4,970		5.0			1,492		2.0
Managed care organizations		1,715		3.6			1,487		4.1			1,968		3.8			1,395		3.8			3,683		3.7			2,882		3.9
Other		283		0.6			89		0.2			228		0.5			103		0.3			511		0.5			192		0.3
Total hospice segment net service revenues	$	47,727		100.0	%	$	36,094		100.0	%	$	52,074		100.0	%	$	36,909		100.0	%	$	99,801		100.0	%	$	73,003		100.0	%
Ohio	$	16,328		34.2	%	$	14,114		39.1	%	$	17,245		33.1	%	$	14,694		39.8	%	$	33,574		33.7	%	$	28,808		39.4	%
Illinois ⁽²⁾		9,541		20.0			—		—			13,561		26.0			—		—			16,078		16.1			—		—
New Mexico		8,233		17.3			9,230		25.6			7,846		15.1			8,717		23.6			23,102		23.1			17,948		24.6
All other states		13,625		28.5			12,750		35.3			13,422		25.8			13,498		36.6			27,047		27.1			26,247		36.0
Total hospice segment net service revenues	$	47,727		100.0	%	$	36,094		100.0	%	$	52,074		100.0	%	$	36,909		100.0	%	$	99,801		100.0	%	$	73,003		100.0	%

Home Health Segment	For the Three Months Ended March 31,										For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2022					2021					2022					2021					2022					2021
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	6,812		73.4	%	$	3,502		80.7	%	$	7,592		72.1	%	$	3,825		81.1	%	$	14,404		72.7	%	$	7,327		80.9	%
Managed care organizations		1,904		20.5			798		18.4			2,262		21.5			822		17.4			4,166		21.0			1,620		17.9
Other		559		6.1			40		0.9			682		6.4			70		1.5			1,241		6.3			110		1.2
Total home health segment net service revenues	$	9,275		100.0	%	$	4,340		100.0	%	$	10,536		100.0	%	$	4,717		100.0	%	$	19,811		100.0	%	$	9,057		100.0	%
New Mexico	$	7,509		81.0	%	$	4,340		100.0	%	$	9,070		86.1	%	$	4,717		100.0	%	$	16,579		83.7	%	$	9,057		100.0	%
Illinois ⁽³⁾		1,766		19.0			—		—			1,466		13.9			—		—			3,232		16.3			—		—
Total home health segment net service revenues	$	9,275		100.0	%	$	4,340		100.0	%	$	10,536		100.0	%	$	4,717		100.0	%	$	19,811		100.0	%	$	9,057		100.0	%

We derive a significant amount of our net service revenues in Illinois, which represented ~~42.4%~~43.8% and ~~35.8%~~38.9% of our net service revenues for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively, and accounted for 41.6% and 37.4% of our net service revenues for the six months ended June 30, 2022 and 2021, respectively.

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 20.7% and ~~20.4%~~22.6% of our net service revenues for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively, and accounted for 20.7% and 21.5% of the Company’s net service revenues for the six months ended June 30, 2022 and 2021, respectively.

On November 26, 2019, the City of Chicago voted to approve additional increases in the Chicago minimum wage to $14 per hour beginning July 1, 2020 and to $15 per hour beginning July 1, 2021. In subsequent years, minimum wage will be increased through a cost of living adjustment capped at 2.5%.

Effective January 1, 2021, the state of Illinois fiscal year 2021 budget increased hourly in-home care rates through the Community Care Program by 7.1%, to $23.40 from $21.84. However, the rate increase was delayed and did not take effect until April 1, 2021, as a result of the

failure of the November 2020 referendum to revise the Illinois income tax code. The Company recognized $2.0 million related to the rate increase for the year ended December 31, 2021, which ~~is expected to be~~was received during the ~~second quarter of~~three and six months ended June 30, 2022.

~~Effective January 1, 2022,~~Originally, the Illinois fiscal year 2022 budget ~~increased~~included a scheduled increase of hourly in-home care rates to ~~$24.96.~~$24.96, to be effective January 1, 2022. On July 12, 2021, in connection with the temporary increase in federal funding for Medicaid ~~home and community-based services~~HCBS authorized by the ARPA, Illinois submitted its Initial Spending Plan and Narrative to CMS for approval. ~~Included in that~~This plan isincluded the acceleration of the rate increase to $24.96 to November 1, 2021 from January 1, 2022 ~~to November 1, 2021. The Company recognized $3.6 million related to the rate increase for the year ended December 31, 2021 which is expected to be received during the second quarter of 2022.~~(i.e., two months earlier). CMS granted partial approval of the Illinois plan, ~~but highlighted~~including the acceleration of the rate increase to November 1, 2021. However, CMS noted that the state will need to submit an amendment for certain Medicaid waiver programs with regard to any rate change ~~methodology. CMS~~methodology and has ~~approved~~highlighted that pay increases for providers of HCBS funded through the ~~waiver amendment~~temporary increase in federal matching funds available under the ARPA will require an updated rate methodology. We recognized revenue of $3.6 million related to the rate increase ~~rates effective November 1, 2021.~~

which $2.1 million was received during the three and six months ended June 30, 2022. The remainder is expected to be received during the third quarter of 2022.

The Illinois fiscal year 2023 budget was signed into law by the Governor on April 19, 2022 and includes a $0.70 rate increase effective January 1, 2023. The Chicago minimum wage ~~is projected to increase~~increased by 2.5% effective July 1, 2022.

Our business will benefit from the rate increases noted above as planned for 2023, but there is no assurance that there will be additional offsetting rate increases in Illinois for fiscal years beyond fiscal year 2023, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

CMS updates the HHPPS payment rates each calendar year. For calendar year 2022, CMS increased HHPPS rates by an estimated 3.2%, which reflects a 3.1% market basket update and a productivity adjustment of negative 0.5 percentage points, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, beginning January 1, 2022, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

Effective January 1, 2022, CMS began implementing a nationwide expansion of the Home Health Value-Based Purchasing (“HHVBP”) Model. Under the model, home health agencies will receive increases or decreases to their Medicare fee-for-service payments of up to 5%, based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later. Calendar year 2023 is the first performance year under the expanded HHVBP Model, which will affect payments in calendar year 2025.

In certain states, payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program applies to home health agencies in Illinois, Ohio, North Carolina, Florida and Texas and may expand, in the future, into additional states. Providers in states subject to the Review Choice Demonstration may initially select from the following claims review and approval processes: pre-claim review, post-payment review or a minimal post-payment review with a 25% payment reduction. Home health agencies that maintain high compliance levels will be eligible for additional options that may be less burdensome. We are currently unable to predict what impact, if any, this program may have on our result of operations or financial position.

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. CMS updates these rates each federal fiscal year. Effective October 1, 2021, CMS increased hospice payment rates by 2.0%. This reflects a 2.7% market basket increase and a negative 0.7 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 2 percentage point reduction to the

market basket update. Beginning in 2024, the reduction to the market basket update for failure to report quality data will increase to 4 percentage points.

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap, which is set each federal fiscal year. The inpatient cap limits the number of days of inpatient care to no more than 20% of total patient care days. The aggregate cap, which limits the total Medicare reimbursement that a hospice may receive based on an annual per-beneficiary cap amount and the number of Medicare patients served, was updated to $31,297.61 for federal fiscal year 2022. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

The New York Consumer Directed Personal Assistance Program (“CDPAP”) is a self-directed care alternative program that allows eligible individuals who need help with activities of daily living or skilled nursing services to choose their caregivers. We provide support services as a CDPAP fiscal intermediary. In 2021, the Company was not selected to enter into contracts as a Lead Fiscal Intermediary and submitted a formal

protest in response to the selection process, which was filed and accepted on March 19, 2021. The Company has not ~~yet~~ received a response to the formal protest.

The New York fiscal year 2023 state budget, passed in April 2022, amends the current Fiscal Intermediary Request For Offer (“RFO”) process to authorize all fiscal intermediaries that submitted an RFO application and served at least 200 clients in New York City or 50 clients in other counties between January 1, 2020 and March 31, 2020 to contract with the New York State Department of Health and continue to operate in all counties contained in their application. Under this provision, the Company ~~would be~~is allowed to continue to contract with all of its current payors for CDPAP services. The Company ~~is currently assessing~~continues to assess the future of its participation in this program. Given the status of the program, the Company suspended materially all of its new patient admissions under the New York CDPAP.

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers andpayors, including federal, state and local governmental agencies, managed care organizations and commercial insurers.

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

We incur direct care wages, payroll taxes and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors and office administrative costs. Personnel costs include wages, payroll taxes and employee benefits. Facility costs include rents, utilities, and postage, telephone and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs and asset write-offs are also included in general and administrative expenses.

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if

applicable, their lease terms.We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was ~~27.9%~~25.1% and ~~19.0%~~26.7% for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively. The effective income tax rates are 26.3% and 23.5% for the six months ended June 30, 2022 and 2021, respectively,, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, ~~and~~ excess tax ~~expense, partially offset by~~expense/benefit and the use of federal employment tax credits.

Three Months Ended ~~March 31,~~June 30, 2022 Compared to Three Months Ended ~~March 31,~~June 30, 2021

The following table sets forth our unaudited condensed consolidated results of operations.

		For the Three Months Ended March 31,																			For the Three Months Ended June 30,
		2022						2021						Change							2022						2021						Change
					% Of						% Of													% Of						% Of
					Net Service						Net Service													Net Service						Net Service
		Amount			Revenues			Amount			Revenues			Amount			%				Amount			Revenues			Amount			Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)																				(Amounts in Thousands, Except Percentages)
Net service revenues		$	226,634			100.0	%	$	205,302			100.0	%	$	21,332			10.4		%	$	236,940			100.0	%	$	217,893			100.0	%	$	19,047			8.7		%
Cost of service revenues			156,448			69.0			144,105			70.2			12,343			8.6				161,342			68.1			149,083			68.4			12,259			8.2
Gross profit			70,186			31.0			61,197			29.8			8,989			14.7				75,598			31.9			68,810			31.6			6,788			9.9
General and administrative expenses			53,152			23.5			45,426			22.1			7,726			17.0				55,095			23.3			48,175			22.1			6,920			14.4
Depreciation and amortization			3,521			1.5			3,601			1.8			(80	)		(2.2	)			3,609			1.5			3,587			1.6			22			0.6
Total operating expenses			56,673			25.0			49,027			23.9			7,646			15.6				58,704			24.8			51,762			23.8			6,942			13.4
Operating income			13,513			6.0			12,170			5.9			1,343			11.0				16,894			7.1			17,048			7.8			(154	)		(0.9	)
Interest income			(58	)		—			(22	)		—			(36	)		163.6				(108	)		—			(31	)		—			(77	)		248.4
Interest expense			1,820			0.8			1,216			0.6			604			49.7				1,986			0.8			1,262			0.6			724			57.4
Total interest expense, net			1,762			0.8			1,194			0.6			568			47.6				1,878			0.8			1,231			0.6			647			52.6
Income before income taxes			11,751			5.2			10,976			5.3			775			7.1				15,016			6.3			15,817			7.3			(801	)		(5.1	)
Income tax expense			3,281			1.5			2,082			1.0			1,199			57.6				3,766			1.6			4,220			1.9			(454	)		(10.8	)
Net income		$	8,470			3.7	%	$	8,894			4.3	%	$	(424	)		(4.8	)	%	$	11,250			4.7	%	$	11,597			5.4	%	$	(347	)		(3.0	)	%

Net service revenues increased by ~~10.4%~~8.7% to ~~$226.6~~$236.9 million for the three months ended ~~March 31,~~June 30, 2022 compared to ~~$205.3~~$217.9 million for the three months ended ~~March 31,~~June 30, 2021. Revenue increased by ~~$11.6~~$15.2 million in our hospice segment and by ~~$4.9~~$5.8 million in our home health segment during the three months ended ~~March 31,~~June 30, 2022, compared to the same period in ~~2021, largely~~2021. The increase in our hospice segment revenue was due to ~~acquisitions. In addition, revenue increased by $4.8 million in our personal care segment, during~~organic growth and the ~~three months ended March 31,~~acquisitions of the operations of JourneyCare on February 1, 2022 ~~compared to the same period in 2021 primarily~~ ~~due to an 8.7% increase in revenues per billable hour, partially offset by a decrease in the New York CDPAP program.~~and Armada on August 1, 2021.

Gross profit, expressed as a percentage of net service revenues, increased to ~~31.0%~~31.9% for the three months ended ~~March 31,~~June 30, 2022, compared to ~~29.8%~~31.6% for the same period in 2021 due to growth in our higher margin hospice segment.

General and administrative expenses increased to ~~$53.2~~$55.1 million for the three months ended ~~March 31,~~June 30, 2022, as compared to ~~$45.4~~$48.2 million for the three months ended ~~March 31,~~June 30, 2021. The increase in general and administrative expenses was primarily due to acquisitions that resulted in an increase in administrative employee wages, taxes and benefit costs of ~~$4.9 million, an increase in acquisition expense of $1.3~~$5.9 million and an increase in rent expense of ~~$0.6~~$0.7 million. General and administrative expenses, expressed as a percentage of net service revenues increased to ~~23.5%~~23.3% for the three months ended ~~March 31,~~June 30, 2022, from 22.1% for the three months ended ~~March 31,~~June 30, 2021.

~~Depreciation and amortization~~Interest expense ~~decreased~~increased to ~~$3.5~~$2.0 million for the three months ended ~~March 31,~~June 30, 2022 from ~~$3.6~~$1.3 million for the three months ended ~~March 31, 2021.~~

~~Interest expense increased to $1.8 million for the three months ended March 31, 2022 from $1.2 million for the three months ended March 31,~~June 30, 2021. The increase in interest expense was primarily due to higher average outstanding borrowings and increased interest rates under our credit facility for the three months ended ~~March 31,~~June 30, 2022 compared to the three months ended ~~March 31,~~June 30, 2021 due to the JourneyCare acquisition.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 25.1% and 26.7% for the three months ended June 30, 2022 and 2021, respectively. The difference between the federal statutory and our effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense/benefit and the use of federal employment tax credits.

The following table sets forth, for the periods indicated, our consolidated results of operations.

	For the Six Months Ended June 30,
	2022						2021						Change
				% Of						% Of
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)
Net service revenues	$	463,574			100.0	%	$	423,195			100.0	%	$	40,379			9.5		%
Cost of service revenues		317,790			68.6			293,188			69.3			24,602			8.4
Gross profit		145,784			31.4			130,007			30.7			15,777			12.1
General and administrative expenses		108,247			23.4			93,601			22.1			14,646			15.6
Depreciation and amortization		7,130			1.5			7,188			1.7			(58	)		(0.8	)
Total operating expenses		115,377			24.9			100,789			23.8			14,588			14.5
Operating income		30,407			6.5			29,218			6.9			1,189			4.1
Interest income		(166	)		—			(53	)		—			(113	)		213.2
Interest expense		3,806			0.8			2,478			0.6			1,328			53.6
Total interest expense, net		3,640			0.8			2,425			0.6			1,215			50.1
Income before income taxes		26,767			5.8			26,793			6.3			(26	)		(0.1	)
Income tax expense		7,047			1.5			6,302			1.5			745			11.8
Net income	$	19,720			4.3	%	$	20,491			4.8	%	$	(771	)		(3.8	)	%

Net service revenues increased by 9.5% to $463.6 million for the six months ended June 30, 2022 compared to $423.2 million for the six months ended June 30, 2021. Net service revenue increased by $26.8 million in our hospice segment and by $10.8 million in our home health segment during the six months ended June 30, 2022, compared to the same period in 2021. During the six months ended June 30, 2022, the increase in our hospice segment revenue was primarily due to an increase in revenue per patient day, attributable to the acquisitions of the operations of JourneyCare on February 1, 2022 and Armada on August 1, 2021, compared to the same period in 2021. Net service revenue increased by $2.8 million in our personal care segment due to an increase in revenues per billable hour for the six months ended June 30, 2022 compared to 2021, partially offset by a decrease in the New York CDPAP program patient admissions.

Gross profit, expressed as a percentage of net service revenues, increased to 31.4% for the six months ended June 30, 2022, compared to 30.7% for the same period in 2021. The increase was mainly attributed to the acquisition of a relatively higher margin hospice business in 2022.

General and administrative expenses increased to $108.2 million for the six months ended June 30, 2022 as compared to $93.6 million for the six months ended June 30, 2021. The increase in general and administrative expenses was primarily due to acquisitions and wage increases that resulted in an increase in administrative employee wages, taxes and benefit costs of $10.8 million and an increase in rent expense of $1.3 million. General and administrative expenses, expressed as a percentage of net service revenues increased to 23.4% for the six months ended June 30, 2022, from 22.1% for the six months ended June 30, 2021.

Interest expense increased to $3.8 million from $2.5 million for the six months ended June 30, 2022, as compared to the six months ended June 30, 2021. The increase in interest expense was primarily due to higher average outstanding borrowings and increased interest rates under our credit facility for the six months ended June 30, 2022, compared to the six months ended June 30, 2021.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was ~~27.9%~~26.3% and ~~19.0%~~23.5% for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, respectively. ~~The~~For the six months ended June 30, 2022, the difference between ~~the~~our federal statutory and ~~our~~ effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, and excess tax expense, partially offset by the use of federal employment tax credits. For the ~~three~~six months ended ~~March 31,~~June 30, 2021, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by the use of federal employment tax credits and excess tax benefit. For the six months ended June 30, 2022 and 2021, the effective tax rates were inclusive of an excess tax expense of ~~2.7%~~1.2% and an excess tax benefit of ~~7.4%~~3.0%, respectively. The excess tax ~~expense or~~ expense/benefit is a discrete item, related to the vesting of equity shares, which requires the Company to recognize the ~~expense or~~ expense/benefit fully in the ~~quarter.~~period.

The following tables and related analysis summarize our operating results and business metrics by segment:

	For the Three Months Ended March 31,																			For the Three Months Ended June 30,																			For the Six Months Ended June 30,
	2022						2021						Change							2022						2021						Change							2022						2021						Change
	Amount			% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount			%				Amount			% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount			%				Amount			% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)																			(Amounts in Thousands, Except Percentages)																			(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	169,632			100.0	%	$	164,868			100.0	%	$	4,764			2.9		%	$	174,330			100.0	%	$	176,267			100.0	%	$	(1,937	)		(1.1	)	%	$	343,962			100.0	%	$	341,135			100.0	%	$	2,827			0.8		%
Cost of services revenues		126,291			74.4			122,839			74.5			3,452			2.8				128,682			73.8			127,258			72.2			1,424			1.1				254,973			74.1			250,097			73.3			4,876			1.9
Gross profit		43,341			25.6			42,029			25.5			1,312			3.1				45,648			26.2			49,009			27.8			(3,361	)		(6.9	)			88,989			25.9			91,038			26.7			(2,049	)		(2.3	)
General and administrative expenses		15,004			8.9			15,283			9.3			(279	)		(1.8	)			15,447			8.9			16,358			9.3			(911	)		(5.6	)			30,451			8.9			31,641			9.3			(1,190	)		(3.8	)
Segment operating income	$	28,337			16.7	%	$	26,746			16.2	%	$	1,591			5.9		%	$	30,201			17.3	%	$	32,651			18.5	%	$	(2,450	)		(7.5	)	%	$	58,538			17.0	%	$	59,397			17.4	%	$	(859	)		(1.4	)	%
Business Metrics (Actual Numbers, Except Billable Hours in Thousands)
Locations at period end		162						164																																161					164
Average billable census * ⁽¹⁾		36,582						38,327						(1,745	)		(4.6	)	%		37,501						38,493						(992	)		(2.6	)	%		37,041						38,410						(1,369	)		(3.6	)	%
Billable hours * ⁽²⁾		7,101						7,567						(466	)		(6.2	)			7,373						7,650						(277	)		(3.6	)			14,474						15,187						(713	)		(4.7	)
Average billable hours per census per month * ⁽²⁾		64.4						65.2						(0.8	)		(1.2	)			65.2						65.9						(0.7	)		(1.1	)			64.8						65.6						(0.8	)		(1.2	)
Billable hours per business day * ⁽²⁾		110,951						118,237						(7,286	)		(6.2	)			113,426						117,688						(4,262	)		(3.6	)			112,198						117,729						(5,531	)		(4.7	)
Revenues per billable hour * ⁽²⁾	$	23.64					$	21.75					$	1.89			8.7		%	$	23.58					$	22.60					$	0.98			4.3		%	$	23.61					$	22.42					$	1.19			5.3		%
Same store growth revenue % * ⁽³⁾		0.9	%					2.4	%												2.5	%					7.4	%												1.7	%					5.9	%

~~The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 42.4% and 35.8% of net service revenues for the~~ ~~three months ended March 31, 2022 and 2021, respectively.~~ One payor, the Illinois Department on Aging, accounted for 20.7% and 20.4% of net service revenues for the three months ended March 31, 2022 and 2021, respectively. Net service revenues from state, local and other governmental programs accounted for 49.5% and 49.0% of net service revenues for the three months ended March 31, 2022 and 2021, respectively. Managed care organizations accounted for 45.6% and 45.8% of net service revenues for the three months ended March 31, 2022 and 2021, respectively, with commercial insurance, private pay and other payors accounting for the remainder of net service revenues.

~~Net service revenues increased by 2.9% for the three months ended March 31, 2022 compared to the three months ended March 31, 2021. Net service revenues increased primarily as a result of an 8.7% increase in revenues per billable hour~~, mainly attributed to rate increases discussed above. The Company experienced a decrease in New York net service revenues of $6.2 million for the three months ended March 31, 2022, primarily driven by a decrease in participation in the New York CDPAP program as discussed above, compared to 2021.

Gross profit, expressed as a percentage of net service revenues, increased to 25.6% for the three months ended March 31, 2022 from 25.5% for the three months ended March 31, 2021. This increase was primarily due to a decrease in direct payroll as a percentage of net service revenues of 0.1% for the three months ended March 31, 2022 as compared to the three months ended March 31, 2021.

~~General and administrative expenses remained relatively consistent for the three months ended March 31, 2022, as compared to the three months ended March 31, 2021.~~

For the Three Months Ended March 31,

2022

2021

Change

Amount

% of
Segment
Net Service
Revenues

Amount

% of
Segment
Net Service
Revenues

Amount

%

(Amounts in Thousands, Except Percentages)

Operating Results

Net service revenues

$
47,727

100.0

%

$
36,094

100.0

%

$
11,633

32.2

%
Cost of services revenues

23,441

49.1

18,596

51.5

4,845

26.1

Gross profit

24,286

50.9

17,498

48.5

6,788

38.8

General and administrative expenses

11,712

24.6

8,463

23.5

3,249

38.4

Segment operating income

$
12,574

26.3

%

$
9,035

25.0

%

$
3,539

39.2

%
Business Metrics (Actual Numbers)

Locations at period end

33

34

Admissions * ⁽¹⁾

3,315

2,394

921

38.5

%
Average daily census * ⁽²⁾

3,320

2,400

920

38.3

Average discharge length of stay * ⁽³⁾

84

101

(17
)

(16.8
)

Patient days * ⁽⁴⁾

275,488

216,007

59,481

27.5

Revenue per patient day * ⁽⁵⁾

$
173.24

$
167.09

$
6.15

3.7

%
Organic growth

- Revenue * ⁽⁶⁾

4.4

%

(8.4
)
%

- Average daily census * ⁽⁶⁾

7.0

%

(20.2
)
%

The ~~hospice~~personal care segment ~~generates~~derives a significant amount of its net service revenues ~~by providing care to patients with a life expectancy~~from operations in Illinois, which represented 43.8% and 38.9% of our net service revenues for the three months ended June 30, 2022 and 2021, respectively, and accounted for 41.6% and 37.4% of our net service revenues for the six months ~~or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet~~ended June 30, 2022 and 2021, respectively. One payor, the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care and continuous home care services, and with ~~the JourneyCare acquisition, expanded into providing general inpatient care services.~~

~~Net service revenues from Medicare~~Illinois Department on Aging, accounted for ~~91.1%~~20.7% and ~~94.2% and managed care organizations accounted for 3.6% and 4.1%~~22.6% of ~~total hospice segment~~ net service revenues for the three months ended ~~March 31,~~June 30, 2022 and 2021, ~~respectively.~~respectively, and accounted for 20.7% and 21.5% of net service revenues for the six months ended June 30, 2022 and 2021, respectively.

Net service revenues ~~increased by $11.6 million~~from state, local and other governmental programs accounted for 49.0% and 50.2% of net service revenues for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively. Managed care organizations accounted for 46.2% and 44.7% of net service revenues for the three months ended June 30, 2022 and 2021, respectively, with commercial insurance, private pay and other payors accounting for the remainder of net service revenues. Net service revenues from state, local and other governmental programs accounted for 49.2% and 49.6% of net service revenues for the six months ended June 30, 2022 and 2021, respectively. Managed care organizations accounted for 45.9% and 45.2% of net service revenues for the six months ended June 30, 2022 and 2021, respectively with commercial insurance, private pay and other payors accounting for the remainder of net service revenues.

Net service revenues decreased by 1.1% and increased by 0.8% for the three and six months ended June 30, 2022, respectively, compared to the three and six months ended ~~March 31, 2021 primarily~~June 30, 2021. Net service revenues included a 4.3% and 5.3% increase in revenues per billable hour for the three and six months ended June 30, 2022, respectively, mainly attributed to ~~organic growth~~rate increases discussed above, as compared to the three and six months ended June 30, 2021. The Company experienced a decrease in New York net service revenues of $4.4 million and $10.6 million for the ~~acquisitions of~~three and six months ended June 30, 2022, primarily driven by a decrease in participation in the ~~operations of JourneyCare on February 1, 2022 and Armada on August 1,~~New York CDPAP program as discussed above, compared to 2021.

Gross profit, expressed as a percentage of net service revenues, ~~was 50.9% and 48.5%~~decreased to 26.2% for the three months ended ~~March 31,~~June 30, 2022 ~~and 2021, respectively.~~ ~~For~~from 27.8% for the three months ended ~~March 31,~~June 30, 2021 and to 25.9% for the six months ended June 30, 2022 from 26.7% for the ~~increase~~six months ended June 30, 2021. This decrease was primarily due to increases in direct payroll as a percentage of net service revenues ~~was mainly attributed~~of 1.9% and 0.9% for the three and six months ended June 30, 2022 as compared to ~~a decrease of direct employee wages, taxes~~the three and ~~benefit costs of 1.5%.~~six months ended June 30, 2021 primarily related to labor wage pressures discussed above.

~~The hospice segment’s general and administrative expenses primarily consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses.~~ General and administrative expenses, expressed as a percentage of net service revenues, was ~~24.6%~~8.9% and ~~23.5%~~9.3% for the three and six months ended ~~March 31,~~June 30, 2022 and 2021, respectively. The increase in general and administrative expenses was primarily due to acquisitions that resulted in a $2.6 million increase in administrative employee wages, taxes and benefit costs and a $0.6 million increase in rent expenses for the three months ended March 31, 2022.

	For the Three Months Ended March 31,																				For the Three Months Ended June 30,																				For the Six Months Ended June 30,
	2022							2021						Change							2022						2021							Change							2022						2021							Change
	Amount				% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount			%				Amount			% of Segment Net Service Revenues			Amount				% of Segment Net Service Revenues			Amount			%				Amount			% of Segment Net Service Revenues			Amount				% of Segment Net Service Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)																				(Amounts in Thousands, Except Percentages)																				(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	9,275				100.0	%	$	4,340			100.0	%	$	4,935			113.7		%	$	52,074			100.0	%	$	36,909				100.0	%	$	15,165			41.1		%	$	99,801			100.0	%	$	73,003				100.0	%	$	26,798			36.7		%
Cost of services revenues		6,716				72.4			2,670			61.5			4,046			151.5				25,522			49.0			18,912				51.2			6,610			35.0				48,963			49.1			37,508				51.4			11,455			30.5
Gross profit		2,559				27.6			1,670			38.5			889			53.2				26,552			51.0			17,997				48.8			8,555			47.5				50,838			50.9			35,495				48.6			15,343			43.2
General and administrative expenses		2,359				25.4			965			22.3			1,394			144.5				13,036			25.0			8,673				23.5			4,363			50.3				24,748			24.8			17,136				23.5			7,612			44.4
Segment operating income	$	200				2.2	%	$	705			16.2	%	$	(505	)		(71.6	)	%	$	13,516			26.0	%	$	9,324				25.3	%	$	4,192			45.0		%	$	26,090			26.1	%	$	18,359				25.1	%	$	7,731			42.1		%
Business Metrics (Actual Numbers)
Locations at period end		12							10																																	33						33
New admissions * ⁽¹⁾		3,336							1,168						2,168			185.6		%
Recertifications * ⁽²⁾		1,316							657						659			100.3
Total volume * ⁽³⁾		4,652							1,825						2,827			154.9
Visits * ⁽⁴⁾		65,213							27,665						37,548			135.7		%
Admissions * ⁽¹⁾																						3,281						2,252							1,029			45.7		%		6,596						4,646							1,950			42.0		%
Average daily census * ⁽²⁾																						3,333						2,460							873			35.5				3,323						2,430							893			36.7
Average discharge length of stay * ⁽³⁾																						84						89							(5	)		(5.8	)			84						96							(12	)		(12.5	)
Patient days * ⁽⁴⁾																						303,289						223,901							79,388			35.5				578,777						439,908							138,869			31.6
Revenue per patient day * ⁽⁵⁾																					$	171.70					$	164.85						$	6.85			4.2		%	$	172.43					$	165.95						$	6.48			3.9		%
Organic growth
- Revenue * ⁽⁵⁾		(0.5	)	%					—	%
- Admissions * ⁽⁵⁾		2.4		%					14.3	%
- Revenue * ⁽⁶⁾																						2.5	%					(8.4	)	%												3.4	%					(8.4	)	%
- Average daily census * ⁽⁶⁾																						6.1	%					(14.3	)	%												6.6	%					(27.2	)	%

The hospice segment generates net service revenues by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care and continuous home care services, and with the JourneyCare acquisition, expanded into providing general inpatient care services. In our hospice segment, net service revenues from Medicare accounted for 90.5% and 93.3% for the three months ended June 30, 2022 and 2021, respectively, and 90.8% and 93.8%for the six months ended June 30, 2022 and 2021, respectively. Net service revenues from managed care organizations accounted for 3.8% for each the three months ended June 30, 2022 and June 30, 2021, and 3.7% and 3.9% for the six months ended June 30, 2022 and 2021, respectively.

Net service revenues increased by $15.2 million and $26.8 for the three and six months ended June 30, 2022, respectively, compared to the three and six months ended June 30, 2021 attributed to organic growth and the acquisitions of the operations of JourneyCare on February 1, 2022 and Armada on August 1, 2021.

Gross profit, expressed as a percentage of net service revenues was 51.0% and 48.8% for the three months ended June 30, 2022 and 2021, respectively, and 50.9% and 48.6%, for the six months ended June 30, 2022 and 2021, respectively. For the three and six months ended June 30, 2022, the increase as a percentage of net service revenues was mainly attributed to decreases in direct employee wages, taxes and benefit costs of 0.3% and 0.8%, respectively.

The hospice segment’s general and administrative expenses primarily consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues was 25.0% and 23.5% for the three months ended June 30, 2022 and 2021, respectively, and 24.8% and 23.5% for the six months ended June 30, 2022 and 2021, respectively. The increase in general and administrative expenses for the three and six months ended June 30, 2022, was due to acquisitions that resulted in a $3.2 million and $5.8 million, respectively, increase in administrative employee wages, taxes and benefit costs.

	For the Three Months Ended June 30,																	For the Six Months Ended June 30,
	2022						2021						Change					2022						2021						Change
	Amount			% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount		%			Amount			% of Segment Net Service Revenues			Amount			% of Segment Net Service Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)																	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	10,536			100.0	%	$	4,717			100.0	%	$	5,819		123.4	%	$	19,811			100.0	%	$	9,057			100.0	%	$	10,754			118.7		%
Cost of services revenues		7,138			67.7			2,913			61.8			4,225		145.0			13,854			69.9			5,583			61.6			8,271			148.1
Gross profit		3,398			32.3			1,804			38.2			1,594		88.4			5,957			30.1			3,474			38.4			2,483			71.5
General and administrative expenses		2,501			23.7			968			20.5			1,533		158.4			4,860			24.5			1,933			21.3			2,927			151.4
Segment operating income	$	897			8.5	%	$	836			17.7	%	$	61		7.3	%	$	1,097			5.5	%	$	1,541			17.0	%	$	(444	)		(28.8	)	%
Business Metrics (Actual Numbers)
Locations at period end																			12					10
New admissions * ⁽¹⁾		3,351						1,186						2,165		182.5	%		6,687						2,354						4,333			184.1		%
Recertifications * ⁽²⁾		1,409						738						671		90.9			2,725						1,395						1,330			95.3
Total volume * ⁽³⁾		4,760						1,924						2,836		147.4			9,412						3,749						5,663			151.1
Visits * ⁽⁴⁾		68,452						31,582						36,870		116.7	%		133,665						59,247						74,418			125.6		%
Organic growth
- Revenue * ⁽⁵⁾		24.6	%					24.7	%										12.6	%					11.5	%
- Admissions * ⁽⁵⁾		25.2	%					29.5	%										13.9	%					21.5	%

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 72.1% and 81.1%, managed care organizations accounted for ~~73.4%~~21.5% and ~~80.7%~~17.4% and ~~20.5%~~other accounted for 6.4% and ~~18.4%, of total home health segment net service revenues~~1.5% for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively. Net service revenues from Medicare accounted for 72.7% and 80.9%, managed care organizations accounted for 21.0% and 17.9% and other accounted for 6.3% and 1.2% for the six months ended June 30, 2022 and 2021, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”). Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

Net service revenues increased by ~~$4.9~~$5.8 million and $10.8 million for the three and six months ended ~~March~~ ~~31,~~June 30, 2022, compared to the three and six months ended ~~March 31,~~June 30, 2021. Total visits increased for the three months ended ~~March 31,~~June 30, 2022, mainly attributed to the acquisition of Armada on August 1, 2021 and Summit on October 1, ~~2021, partially offset by a decrease in revenue related to the Omicron surge.~~2021.

Gross profit, expressed as a percentage of net service ~~revenu~~esrevenues was ~~27.6%~~32.3% and ~~38.5%~~38.2% for the three months ended ~~March 31,~~June 30, 2022 and 2021, ~~respectively.~~respectively, and 30.1% and 38.4%, for the six months ended June 30, 2022 and 2021, respectively. For the three and six months ended ~~March 31,~~June 30, 2022, the decrease was primarily due to an increase of direct employee wages, taxes and benefit costs of

~~8.7%~~ 5.7% and 7.1%, respectively, as a percentage of net service ~~revenues compared to the three months ended March 31, 2021.~~ ~~Cost of service for the three months ended March 31, 2022 increased compared to the corresponding period in 2021, due to an increase in clinical caregiver training.~~revenues.

The home health segment’s general and administrative expenses primarily consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues was ~~25.4%~~23.7% and ~~22.3%, respectively,~~20.5% for the three months ended ~~March 31,~~June 30, 2022 and 2021, ~~respectively.~~respectively, and 24.5% and 21.3% for the six months ended June 30, 2022 and 2021, respectively. The increase in general and administrative expenses was primarily due to acquisitions that resulted in a $1.2 million and $2.5 million increase in administrative employee wages, taxes and benefit costs for the three and six months ended ~~March 31,~~June 30, 2022.

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At ~~March 31,~~June 30, 2022 and December 31, 2021, we had cash balances of ~~$124.8~~$120.9 million and $168.9 million, respectively. At ~~March 31,~~June 30, 2022, we had a $600.0 million revolving credit facility and a $125.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2026.

During the ~~three~~six months ended ~~March 31,~~June 30, 2022, we (i) drew $35.0 million under our revolving credit facility to fund, in part, the JourneyCare ~~acquisition.~~acquisition and (ii) repaid $60.0 million under our revolving credit facility. ~~At March 31,~~As of June 30, 2022, we had a total of ~~$259.9~~$199.9 million in revolving loans, with an interest rate of ~~2.46%~~3.67% outstanding on its credit facility and after giving effect to the amount drawn on our credit facility, approximately $8.1 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had ~~$377.6~~$376.4 million of capacity and ~~$109.6~~$168.4 million available for borrowing under our credit facility. At December 31, 2021, we had a total of $224.9 million revolving credit loans,, with an interest rate of 2.10%, outstanding on our credit facility.

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At ~~March 31,~~June 30, 2022, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

See Note 8 to the Notes to Condensed Consolidated Financial Statements,, Long-Term Debt, for additional details of our long-term debt.

As a result of the COVID-19 pandemic, federal and state governments have passed legislation, promulgated regulations, and taken other administrative actions intended to assist healthcare providers in providing care to COVID-19 patients and other patients during the public health emergency. These temporary measures include relief from Medicare conditions of participation requirements for healthcare providers, relaxation of licensure requirements for healthcare professionals, relaxation of privacy restrictions for telehealth remote communications, promoting use of telehealth by expanding the scope of services for which Medicare reimbursement is available, and limited waivers of fraud and abuse laws for activities related to COVID-19 during the emergency period. The current federal public health emergency declaration expires ~~July 15,~~October 13, 2022, but HHS has indicated it will provide states with 60 days’ notice prior to termination of the declaration.

In November 2020, the Company received grants in an aggregate principal amount of $13.7 million from the Provider Relief Fund, and fully utilized these funds as of December 31, 2021, including ~~$0.9~~$10.4 million and $11.3 million during the three and six months ended ~~March 31,~~June 30, 2021, for healthcare related expenses, including retention payments, attributable to COVID-19 that were unreimbursed by other sources. We were required to properly and fully document the use of such funds in reports to HHS, which we were required to submit no later than March 31, 2022. We have submitted the required reports.

The CARES Act allowed for the deferral of the employer portion of Social Security payroll taxes through December 31, 2020. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the deferred portion of employer Social Security payroll taxes was $4.1 million, which is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets. The payroll tax deferral requires that the remaining deferred payroll taxes be paid by December 31, 2022.

The ARPA, which became law on March 11, 2021, provided for $350 billion in relief funding for eligible state, local, territorial and ~~Tribal~~tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain

~~conditions.~~onditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, ~~2024.~~2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

For certain states, the Company must implement efforts and expend funds primarily for the further recruitment, retention and training of caregivers and funds may be subject to recoupment if not expended or are expended on non-approved uses. In addition, the Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. During the six months ended June 30, 2022, the Company received state funding provided by the ARPA in an aggregate amount of $14.6 million. The Company recorded revenue of $1.6 million and related cost of service revenues of $1.2 million for certain states that met the revenue recognition criteria. The Company deferred the remaining $13.0 million, which was received from states with specific spending plans and reporting requirements. The Company utilized $0.4 million of these funds during the three and six months ended June 30, 2022, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2022, the deferred portion of ARPA funding was $12.6 million, which is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

The CARES Act and related legislation temporarily lifted the Medicare sequester that would have otherwise reduced payments to Medicare providers by 2% as required by the Budget Control Act of 2011, from May 1, 2020 through December 31, 2021. Congress further delayed these sequestration cuts through March 31, 2022, and reduced the sequestration adjustment to 1% from April 1 through June 30, 2022. The full 2% reduction ~~is currently scheduled to resume~~resumed July 1, 2022. These sequestration cuts have been extended through 2030, with the reductions for 2030 set to increase to 2.25% for the first six months and to 3% for the second six months.

In our hospice segment, Medicare sequester relief resulted in an increase in net service revenues of ~~$0.9~~$0.5 million and $0.7 million for the three months ended ~~March 31,~~June 30, 2022 and 2021, ~~respectively.~~respectively, and $1.4 million for each of the six months ended June 30, 2022 and 2021. In our home health segment, Medicare sequester relief resulted in an increase in net service revenues of ~~$0.2 million and~~ $0.1 million for each of the three months ended ~~March 31,~~June 30, 2022 and 2021, and $0.3 million and $0.2 million for the six months ended June 30, 2022 and 2021, respectively.

The ARPA increases the federal budget deficit in a manner that triggers an additional statutorily mandated sequestration under the PAYGO Act. As a result, an additional Medicare payment reduction of up to 4% was required to take effect in January 2022. However, Congress has delayed implementation of this payment reduction until 2023. We cannot currently determine if, or to what extent, our business, results of operations, financial condition or liquidity will ultimately be impacted by mandated sequestration triggers under the PAYGO Act, or if or when the mandated sequestration will occur.

See Note 7 to the Notes to Condensed Consolidated Financial Statements, COVID-19 Pandemic, for additional details of the COVID-19 pandemic.

The following table summarizes changes in our cash ~~flows for the three months ended March 31, 2022 and 2021:~~flows:

	For the Three Months Ended March 31,						For the Six Months Ended June 30,
	2022			2021			2022			2021
	(Amounts in Thousands)						(Amounts in Thousands)
Net cash provided by (used in) operating activities	$	5,983		$	(18,366	)	$	62,502		$	(3,321	)
Net cash used in investing activities		(85,594	)		(1,021	)		(86,028	)		(1,928	)
Net cash provided by (used in) financing activities		35,479			(144	)
Net cash used in financing activities								(24,452	)		(429	)

~~Three~~Six Months Ended ~~March 31,~~June 30, 2022 Compared to ~~Three~~Six Months Ended ~~March 31,~~June 30, 2021

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest and taxes. Net cash provided by operating activities was ~~$6.0~~$62.5 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, compared to net cash used byin operating activities of ~~$18.4~~$3.3 million for the same period in 2021. The increase in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the ~~three~~six months ended ~~March 31,~~June 30, 2022 compared to 2021, as described below. The related receivables due from the Illinois Department on Aging represented 18.3% and 16.1% of the Company’s net accounts receivable at ~~both March 31,~~June 30, 2022 and December 31, 2021, respectively, as discussed below.

Net cash used in investing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2022, primarily consisted of $84.5 million of net cash used for the JourneyCare acquisition. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, property and equipment purchases, primarily related to our ongoing investments in our technology infrastructure, were ~~$1.1~~$1.5 million and ~~$1.0~~$1.8 million, respectively.

~~Our~~Net cash used in financing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2022, ~~included~~primarily related to a $60.0 million payment on the revolver portion of our credit facility, partially offset by borrowings of $35.0 million on the revolver portion of our credit facility to fund, in part, the JourneyCare acquisition. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, net cash provided by financing activities included cash received from the exercise of stock options of $0.5 million and $0.1 million, respectively.

Gross accounts receivable as of ~~March 31,~~June 30, 2022 and December 31, 2021 were approximately ~~$138.2~~$125.9 million and $138.4 million, respectively. Outstanding accounts receivable, net of allowance for credit losses, decreased by ~~$0.1~~$12.4 million as of ~~March 31,~~June 30, 2022 as compared to December 31, 2021. Accounts receivable for the Illinois Department on Aging dei~~creased~~ncreased approximately ~~$0.2~~$0.1 million during the quarter ended ~~March 31,~~June 30, 2022. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 5246 days and 54 days at ~~March 31,~~June 30, 2022 and December 31, ~~2021.~~2021, respectively. The ~~DSO~~DSOs for our largest payor, the Illinois Department on Aging, was 43 days at both ~~March 31,~~June 30, 2022 and December 31, 2021.

As of ~~March 31,~~June 30, 2022, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2021, filed on February 25, 2022.

Refer to Note 2 to the Notes to Condensed Consolidated Financial Statements (Unaudited) for further discussion.

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of ~~March 31,~~June 30, 2022, we had outstanding borrowings of approximately ~~$109.6~~$199.9 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the three ~~months period~~and six month periods ended ~~March 31,~~June 30, 2022, our net income would have decreased by $0.4 million, or $0.03 per diluted ~~share.~~share, and $1.2 million, or $0.08 per diluted share, respectively. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of ~~March 31,~~June 30, 2022. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of ~~March 31,~~June 30, 2022.

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended ~~March 31,~~June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 25, 2022. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Incorporated by Reference

Exhibit

Number

Description of Document

Form

File No.

Date Filing

Exhibit

Number

Description of Document

Form

File No.

Date Filing

Exhibit

Number

3.1

Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.

10-Q

001-34504

11/20/2009

3.1

Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.

10-Q

001-34504

11/20/2009

3.1

3.2

Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.

10-Q

001-34504

05/9/2013

3.2

Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.

10-Q

001-34504

05/9/2013

3.2

4.1

Form of Common Stock Certificate.

S-1

333-160634

10/2/2009

4.1

Form of Common Stock Certificate.

S-1

333-160634

10/2/2009

4.1

10.1*

Amended and Restated Employment and Non-Competition Agreement, effective March 1, 2022, by and between Addus HealthCare, Inc. and Monica Raines.

Employment and Non-Competition Agreement, effective April 20, 2022, by and between Addus HealthCare, Inc. and Cliff Blessing.

31.1

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Calculation Linkbase Document.

101.LAB

Inline XBRL Taxonomy Label Linkbase Document.

101.PRE

Inline XBRL Presentation Linkbase Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



Delaware		20-5340172
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

6303 Cowboys Way, Suite 600 Frisco, TX		75034
(Address of principal executive offices)		(Zip Code)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	ADUS	The Nasdaq Global Market


PART I. FINANCIAL INFORMATION	3

Item 1. Financial Statements (Unaudited)	3

Condensed Consolidated Balance Sheets as of ~~March 31,~~June 30, 2022 and December 31, 2021	3

Condensed Consolidated Statements of Income For the Three and Six Months Ended ~~March 31,~~June 30, 2022 and 2021	4

Condensed Consolidated Statement of Stockholders’ Equity For the Three and Six Months Ended ~~March 31,~~June 30, 2022 and 2021	5

Condensed Consolidated Statements of Cash Flows For the ~~Three~~Six Months Ended ~~March 31,~~June 30, 2022 and 2021	67

Notes to Condensed Consolidated Financial Statements	78

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	1821

Item 3. Quantitative and Qualitative Disclosures About Market Risk	3135

Item 4. Controls and Procedures	3135

PART II. OTHER INFORMATION	3236

Item 1. Legal Proceedings	3236

Item 1A. Risk Factors	3236

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	3236

Item 3. Defaults Upon Senior Securities	3236

Item 4. Mine Safety Disclosures	3236

Item 5. Other Information	3236

Item 6. Exhibits	3337


	ADDUS HOMECARE CORPORATION

Date: ~~May 3,~~August 2, 2022	By:	/s/ R. DIRK ALLISON

		R. Dirk Allison Chairman and Chief Executive Officer (As Principal Executive Officer)

Date: ~~May 3,~~August 2, 2022	By:	/s/ BRIAN POFF

		Brian Poff Chief Financial Officer (As Principal Financial Officer)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Large Accelerated Filer

Accelerated Filer

Non-Accelerated Filer

Smaller Reporting Company

Emerging Growth Company